Psiquiatría
Servizo
Universitat de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat de Barcelona (93)
2024
-
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders
Biological Psychiatry
-
Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation
Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338
-
Cognitive and clinical predictors of a long-term course in obsessive compulsive disorder: A machine learning approach in a prospective cohort study
Journal of Affective Disorders, Vol. 350, pp. 648-655
-
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe
Psychological Medicine
2023
-
Anxiety and depression played a central role in the COVID-19 mental distress: A network analysis
Journal of Affective Disorders, Vol. 338, pp. 384-392
-
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384
-
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Psychiatry Research, Vol. 323
-
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106
-
Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder
Revista de Psiquiatria y Salud Mental
-
Neuropsychiatric symptoms in a patient under cystic fibrosis transmembrane conductance regulator modulators treatment: A case report
International Clinical Psychopharmacology, Vol. 38, Núm. 6, pp. 402-405
-
Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis
European Neuropsychopharmacology, Vol. 66, pp. 30-44
-
Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study
Psychological Medicine, Vol. 53, Núm. 5, pp. 1970-1978
-
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study
Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580
-
Tobacco use in first-episode psychosis, a multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276
-
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; The EU-GEI study
Psychological Medicine, Vol. 53, Núm. 8, pp. 3396-3405
2022
-
A replication study of JTC bias, genetic liability for psychosis and delusional ideation
Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783
-
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86